business
Makers of obesity drugs hit back at claims of negative side effects
Confidence92·multiple reportsImportance94NP-EVT-20261114-7FC0059
Novo and Eli Lilly respond to concerns that their blockbuster GLP-1 medicines can lead to problems including poor nutrition
Read the original at the primary source
Makers of obesity drugs hit back at claims of negative side effects
11/14/2026, 11:00:09 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indias · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —